GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intercure Ltd (TSX:INCR.U) » Definitions » Debt-to-Equity

Intercure (TSX:INCR.U) Debt-to-Equity : 0.53 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Intercure Debt-to-Equity?

Intercure's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $22.17 Mil. Intercure's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $40.98 Mil. Intercure's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $118.59 Mil. Intercure's debt to equity for the quarter that ended in Dec. 2024 was 0.53.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Intercure's Debt-to-Equity or its related term are showing as below:

TSX:INCR.U' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02   Med: 0.24   Max: 0.65
Current: 0.53

During the past 13 years, the highest Debt-to-Equity Ratio of Intercure was 0.65. The lowest was 0.02. And the median was 0.24.

TSX:INCR.U's Debt-to-Equity is ranked worse than
68.88% of 813 companies
in the Drug Manufacturers industry
Industry Median: 0.26 vs TSX:INCR.U: 0.53

Intercure Debt-to-Equity Historical Data

The historical data trend for Intercure's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intercure Debt-to-Equity Chart

Intercure Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.24 0.51 0.43 0.53

Intercure Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Jun24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.32 0.43 0.33 0.53

Competitive Comparison of Intercure's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Intercure's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intercure's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intercure's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Intercure's Debt-to-Equity falls into.


;
;

Intercure Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Intercure's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Intercure's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intercure  (TSX:INCR.U) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Intercure Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Intercure's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Intercure Business Description

Traded in Other Exchanges
Address
85 Medinat ha-Yehudim Street, Herzliya, ISR, 4676670
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Intercure Headlines

No Headlines